glp-1 grocery news Why food makers aren't afraid of drugs GLP-1 drugs creating 'seismic shift'

Despite likely being a similar tier as GLP-1 RAs and SGLT2is for many patient insurances, this elevated AWP is important to note for patients with co-insurances, deductibles, the Medicare coverage gap, patients without insurance, and for the total cost of healthcare

The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration

[DOI] [PubMed] [Google Scholar] 117.Baldini G., Phelan K.D

Patients who have never been on GLP-1 treatment can go from intake to prescription decision within 24 to 48 hours

Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats